POPULATION BASED STUDY OF THE PREVALENCE OF EGFR MUTATIONS IN NON-SMALL CELL LUNG CANCER (NSCLC)

被引:0
|
作者
Skov, Birgit G. [1 ]
Hogdall, Estrid [2 ]
Clementsen, Paul [3 ]
Krasnik, Mark [1 ]
Larsen, Klaus R. [4 ]
Sorensen, Jens B. [1 ]
Mellemgaard, Anders [5 ]
机构
[1] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark
[2] Herlev Univ Hosp, Herlev, Denmark
[3] Gentofte Univ Hosp, Hellerup, Denmark
[4] Bispebjeg Univ Hosp, Copenhagen, Denmark
[5] Univ Copenhagen, Herlev Univ Hosp, DK-1168 Copenhagen, Denmark
关键词
EGFR mutations; Cytology; population based; NSCLC;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.06-022
引用
收藏
页码:S1082 / S1083
页数:2
相关论文
共 50 条
  • [31] Prevalence and Patterns of EGFR Mutations in Non-small Cell Lung Cancer in the Middle East and North Africa
    Boustany, Youssra
    Laraqui, Abdelilah
    El Rhaffouli, Hicham
    Bajjou, Tahar
    El Mchichi, Bouchra
    El Anaz, Hicham
    Amine, Idriss Lahlou
    Chahdi, Hafsa
    Oukabli, Mohammed
    Souhi, Hicham
    Elouazzani, Hanane
    Rhorfi, Ismail Abderrahmani
    Abid, Ahmed
    Mahfoud, Tarik
    Tanz, Rachid
    Ichou, Mohammed
    Ennibi, Khaled
    Belkadi, Bouchra
    Sekhsokh, Yassine
    CANCER CONTROL, 2022, 29
  • [32] Prevalence of EGFR gene fusions in a large cohort of Chinese patients with non-small cell lung cancer (NSCLC).
    Xu, Chunwei
    Wang, Wen Xian
    Chen, Yu
    Zhu, You-cai
    Liu, Yueping
    Wang, Hong
    Zhuang, Wu
    Chen, Xiaohui
    Huang, Yun-jian
    Lai, Jinhuo
    Fang, Meiyu
    Zhang, Zhenghua
    Tao, Ye
    Xu, Shuguang
    Qian, Xue
    Zhao, Hongyu
    Ma, Jing
    Chen, Gang
    Lv, Tangfeng
    Song, Yong
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] European prevalence of Epidermal Growth Factor Receptor (EGFR) mutations in patients with Non-small Cell Lung Cancer (NSCLC): A meta-analysis
    Haentschel, M.
    Kambartel, K.
    Melosky, B.
    Cappuzzo, F.
    Bennetts, M.
    Nickens, D. J.
    Brinkmann, J.
    Kayser, A.
    Moran, M.
    Laack, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 143 - 144
  • [34] ONCOGENIC DRIVER MUTATIONS IN CHINESE NON-SMALL CELL LUNG CANCER (NSCLC)
    He, J.
    Yang, H.
    Deng, Q.
    He, P.
    Jiang, J.
    Zhao, M.
    Gu, X.
    Zheng, L.
    Pang, H.
    Zhou, J. X.
    ANNALS OF ONCOLOGY, 2012, 23 : 389 - 390
  • [35] Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC).
    Liu, Stephen, V
    Vanderwalde, Ari M.
    Mamdani, Hirva
    Raez, Luis E.
    Baca, Yasmine
    Xiu, Joanne
    Korn, Wolfgang Michael
    Nagasaka, Misako
    Pai, Sachin Gopalkrishna
    Socinski, Mark A.
    Nieva, Jorge J.
    Kim, Chul
    Wozniak, Antoinette J.
    Ikpeazu, Chukwuemeka
    Lopes, Gilberto
    Spira, Alexander, I
    Judd, Julia
    Kim, Edward S.
    Borghaei, Hossein
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [36] EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study
    Bircan, Sema
    Baloglu, Huseyin
    Kucukodaci, Zafer
    Bircan, Ahmet
    MEDICAL ONCOLOGY, 2014, 31 (08)
  • [37] EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study
    Sema Bircan
    Huseyin Baloglu
    Zafer Kucukodaci
    Ahmet Bircan
    Medical Oncology, 2014, 31
  • [38] Cytological samples for the study of EGFR, KRAS and ALK mutations in non-small cell lung cancer
    Becker, Caroline
    Carcereny Costa, Enric
    Andreo Garcia, Felipe
    Castella, Eva
    Lletjos Sanuy, Mariona
    Moran, Teresa
    Mijangos Basterra, Erika
    Sanz Santos, Jose
    Centeno Clemente, Carmen
    Ruiz Manzano, Juan
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [40] Current management of uncommon EGFR mutations in non-small cell lung cancer
    Trinh, Jonathan Q.
    Abughanimeh, Omar
    CURRENT PROBLEMS IN CANCER, 2024, 49